Seriniquinone, metabolite from a marine bacterium, and its synthetic derivative for melanoma and resistant melanoma cells treatment (2020)
- Authors:
- USP affiliated authors: LOTUFO, LETICIA VERAS COSTA - ICB ; HIRATA, AMANDA SOARES - ICB ; BRANCO, PAOLA CRISTINA - ICB ; TEIXEIRA, PAULA REZENDE - ICB
- Unidade: ICB
- DOI: 10.3390/md18010040
- Subjects: METABÓLITOS SECUNDÁRIOS; PRODUTOS NATURAIS; EXPRESSÃO GÊNICA; REGULAÇÃO GÊNICA; MELANOMA; CÉLULAS CULTIVADAS DE TUMOR
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Marine Drugs
- ISSN: 1660-3397
- Volume/Número/Paginação/Ano: v. 18, n. 1, p. 114, 2020
- Conference titles: International Symposium on Marine Natural Products
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
HIRATA, Amanda S. et al. Seriniquinone, metabolite from a marine bacterium, and its synthetic derivative for melanoma and resistant melanoma cells treatment. Marine Drugs. Basel: MDPI AG. Disponível em: https://doi.org/10.3390/md18010040. Acesso em: 04 ago. 2025. , 2020 -
APA
Hirata, A. S., Branco, P. C., Rezende-Teixeira, P., Jimenez, P. C., Clair, J. J. L., Fenical, W., & Costa-Lotufo, L. V. (2020). Seriniquinone, metabolite from a marine bacterium, and its synthetic derivative for melanoma and resistant melanoma cells treatment. Marine Drugs. Basel: MDPI AG. doi:10.3390/md18010040 -
NLM
Hirata AS, Branco PC, Rezende-Teixeira P, Jimenez PC, Clair JJL, Fenical W, Costa-Lotufo LV. Seriniquinone, metabolite from a marine bacterium, and its synthetic derivative for melanoma and resistant melanoma cells treatment [Internet]. Marine Drugs. 2020 ; 18( 1): 114.[citado 2025 ago. 04 ] Available from: https://doi.org/10.3390/md18010040 -
Vancouver
Hirata AS, Branco PC, Rezende-Teixeira P, Jimenez PC, Clair JJL, Fenical W, Costa-Lotufo LV. Seriniquinone, metabolite from a marine bacterium, and its synthetic derivative for melanoma and resistant melanoma cells treatment [Internet]. Marine Drugs. 2020 ; 18( 1): 114.[citado 2025 ago. 04 ] Available from: https://doi.org/10.3390/md18010040 - Seriniquinones as therapeutic leads for treatment of BRAF and NRAS mutant melanomas
- What can we learn from commercial insecticides? Efficacy, toxicity, environmental impacts, and future developments
- Enriching cancer pharmacology with drugs of marine origin
- Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma
- Uncovering metabolic alterations in HCT-116 colon cancer cells upon exposure to bamboo leaf extract obtained from Guadua incana Londoño
- Antitumoral activity of different Amaryllidaceae alkaloids: in vitro and in silico assays
- Metabolomic profiling of Guadua species and its correlation with antioxidant and cytotoxic activities
- Anticancer potential of compounds from the Brazilian Blue Amazon
- Avaliação do potencial anti-tirosinase e citotóxico de extratos de Pimenta pseudocaryophyllus (GOMES) landrum
- Caracterização do mecanismo de ação da seriniquinona e derivados sintéticos em modelos celulares de melanoma
Informações sobre o DOI: 10.3390/md18010040 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
